Stress- and antidepressant treatment-induced modifications of 5-HT 7 receptor functions in the rat brain

Pharmacological Reports

Volumn 64, Issue 6, 2012, Pages 1305-1315

  Tokarski, Krzysztof ^a   Bobula, Bartosz ^a   Grzegorzewska Hiczwa, Małgorzata ^a   Kusek, Magdalena ^a   Hess, Grzegorz ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Antidepressants; Brain slices; Frontal cortex; Hippocampus; Model of stress; Serotonin receptors

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; BRAIN PROTEIN; CELL PROTEIN; CITALOPRAM; CLOMIPRAMINE; CLORGYLINE; CORTICOSTERONE; DESIPRAMINE; DOPAMINE; DR 4004; FLUOXETINE; GLUTAMIC ACID; HYDROCORTISONE; IMIPRAMINE; LITHIUM; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN; PROTEIN GA12; PROTEIN GAS; SEROTONIN 1A RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN 7 RECEPTOR SELECTIVE ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AFTERHYPERPOLARIZATION; ANIMAL BEHAVIOR; ANTIDEPRESSANT ACTIVITY; BINDING AFFINITY; CIRCADIAN RHYTHM; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG BINDING; DRUG POTENTIATION; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; EXCITATORY POSTSYNAPTIC POTENTIAL; FRONTAL CORTEX; GABAERGIC TRANSMISSION; GLUTAMATERGIC TRANSMISSION; HIPPOCAMPAL CA1 REGION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMOBILIZATION STRESS; INHIBITORY POSTSYNAPTIC POTENTIAL; LIMBIC SYSTEM; LONG TERM CARE; LONG TERM POTENTIATION; MEMBRANE DEPOLARIZATION; MEMORY DISORDER; MOOD DISORDER; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE CONDUCTION; NERVE EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; PYRAMIDAL NERVE CELL; RECEPTOR BLOCKING; RECEPTOR DENSITY; REM SLEEP; REPEATED DRUG DOSE; REVIEW; RISK FACTOR; SEROTONIN RELEASE; SINGLE DRUG DOSE; SYNAPTIC TRANSMISSION;

EID: 84873735516     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70928-3     Document Type: Review

References (109)

1. AbbasAI, HedlundPB, HuangXP, TranTB, MeltzerHY, RothBL: Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl), 2009, 205, 119-128.
2. Alfarez DN, Joëls M, Krugers HJ: Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. Eur J Neurosci, 2003, 17, 1928-1934. (Pubitemid 36645342)
3. AltA, NisenbaumES, BleakmanD, WitkinJM: A role for AMPA receptors in mood disorders. Biochem Pharmacol, 2007, 71, 1273-1288.
4. AntleMC, OgilvieMD, PickardGE, MistlbergerRE: Response of the mouse circadian system to serotonin 1A/2/7 agonists in vivo: surprisingly little. J Biol Rhythms, 2003, 18, 145-158.
5. Bacon WL, Beck SG: 5-Hydroxytryptamine7 receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther, 2000, 294, 672-679. (Pubitemid 30490844)
6. 7) positively linked to adenylate cyclase. J Biol Chem, 1993, 268, 23422-23426.
7. Bermack J, Lavoie N, Dryver E, Debonnel G: Effects of sigma ligands on NMDA receptor function in the bulbectomy model of depression: a behavioural study in the rat. Int J Neuropsychopharmacol, 2002, 5, 53-62. (Pubitemid 34241067)
8. Bickmeyer U, Heine M, Manzke T, Richter DW: Differential modulation of I(h) by 5-HT receptors in mouse CA1 hippocampal neurons. Eur J Neurosci, 2002, 16, 209-218. (Pubitemid 36160241)
9. Bijak M, Misgeld U: Effects of serotonin through serotonin1A and serotonin4 receptors on inhibition in the guinea-pig dentate gyrus in vitro. Neuroscience, 1997, 78, 1017-1026. (Pubitemid 27223708)
10. 4 receptor activation in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol, 1997, 355, 14-19.
11. BobulaB, WabnoJ, HessG: Imipramine counteracts corticosterone-induced enhancement of glutamatergic transmission and impairment of long-term potentiation in rat frontal cortex. Pharmacol Rep, 2011, 63, 1404-1412.
12. 7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther, 2007, 321, 690-698.
13. 1A receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors. J Neurochem, 2006, 96, 853-860.
14. Cardenas CG, Mar LP, Vysokanov AV, Arnold PB, Cardenas LM, Surmeier DJ, Scroggs RS: Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol, 1999, 518, 507-523. (Pubitemid 29366746)
15. Castro EM, Diaz A, del Olmo E, Pazos A: Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology, 2003, 44, 93-101. (Pubitemid 36135846)
16. 7 receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization. J Pharmacol Exp Ther, 2001, 297, 395-402.
17. Chapin EM, Andrade R: A 5-HT7 receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h). J Pharmacol Exp Ther, 2001, 297, 403-409. (Pubitemid 32242602)
18. ChenL, YungKK, ChanYS, YungWH: 5-HT excites globus pallidus neurons by multiple receptor mechanisms. Neuroscience, 2008, 151, 439-451.
19. CorsetV, Nguyen-Ba-CharvetKT, ForcetC, MoyseE, ChédotalA, MehlenP: Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor. Nature, 2000, 407, 747-750.
20. Doly S, Fischer J, Brisorgueil M-J, Vergé D, Conrath M: Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence. J Comp Neurol, 2005, 490, 256-269. (Pubitemid 41140992)
21. DuncanMJ, TemelS, JennesL: Localisation of serotonin 5-HT7 receptor immunoreactivity in the rat brain. Soc Neurosci Abstr, 2001, 380, 18.
22. Ehlen JC, Grossman GH, Glass JD: In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus. J Neurosci, 2001, 21, 5351-5357. (Pubitemid 32622961)
23. FinkKB, GothertM: 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev, 2007, 59, 360-417.
24. FreundTF: Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci, 2003, 26, 489-495.
25. Freund TF, Buzsaki GL: Interneurons of the hippocampus. Hippocampus, 1996, 6, 347-470. (Pubitemid 126682925)
26. Ganong AH, Cotman CW: Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus. J Pharmacol Exp Ther, 1986, 236, 293-299. (Pubitemid 16186161)
27. Garraway SM, Hochman S: Pharmacological characterization of serotonin receptor subtypes modulating primary afferent input to deep dorsal horn neurons in the neonatal rat. Br J Pharmacol, 2001, 132, 1789-1798. (Pubitemid 32397971)
28. Gadek-Michalska A, Bugajski J: Repeated handling, restraint, or chronic crowding impair the hypothalamic-pituitary-adrenocortical response to acute restraint stress. J Physiol Pharmacol, 2003, 54, 449-459. (Pubitemid 37169008)
29. Glass JD, Grossman GH, Farnbauch L, DiNardo L: Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. J Neurosci, 2003, 23, 7451-7460. (Pubitemid 37034061)
30. 1B receptor agonist in the rat prefrontal cortex. Pol J Pharmacol, 2002, 54, 625-631.
31. Gregus A, Wintink AJ, Davis AC, Kalynchuk LE: Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res, 2005, 156, 105-114. (Pubitemid 39330441)
32. 7 receptor suggest therapeutic potential in depression. Neuropharmacology, 2005, 48, 492-502.
33. 3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Neurochem Res, 2004, 29, 1487-1497.
34. 7 receptor and disorders of the nervous system: an overview Psychopharmacology (Berl), 2009, 206, 345-354.
35. 7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry, 2005, 58, 831-837.
36. 7 receptor research. Trends Pharmacol Sci, 2004, 25, 481-486.
37. 1A/7 receptor agonists accompanied by reduced Perland Per2 mRNA levels in the suprachiasmatic nuclei. J Neurosci, 2000, 20, 5867-5873.
38. Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav, 2002, 71, 533-554. (Pubitemid 34219205)
39. IyoAH, FeyissaAM, ChandranA, AustinMC, RegunathanS, KarolewiczB: Chronic corticosterone administration down-regulates metabotropic glutamate receptor 5 protein expression in the rat hippocampus. Neuroscience, 2010, 169, 1567-1574.
40. JacobsBL, AzmitiaEC: Structure and function of the brain serotonin system. Physiol Rev, 1992, 72, 165-229.
41. Jaffe AB, Hall A: Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol, 2005, 21, 247-269. (Pubitemid 41740635)
42. Jin R, Clark S, Weeks AM, Dudman JT, Gouaux E, Partin KM: Mechanism of positive allosteric modulators acting on AMPA receptors. J Neurosci, 2005, 25, 9027-9036. (Pubitemid 41384472)
43. 7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurones. J Physiol, 1994, 478, 67-73.
44. Keedwell PA, Andrew C, Williams SC, Brammer MJ, Phillips ML: The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry, 2005, 58, 843-853. (Pubitemid 41790711)
45. KrishnanV, NestlerEJ: Molecular neurobiology of depression. Nature, 2008, 455, 894-902.
46. Kugaya A, Sanacora G: Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr, 2005, 10, 808-819. (Pubitemid 41531934)
47. Kvachnina E, Liu G, Dityatev A, Renner U, Dumuis A, Richter DW, Dityateva G: 5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J Neurosci, 2005, 25, 7821-7830. (Pubitemid 41208654)
48. LeschKP, AulakhCS, TolliverTJ, HillJL, MurphyDL: Regulation of G proteins by chronic antidepressant drug treatment in rat brain: tricyclics but not clorgyline increase Go alpha subunits. Eur J Pharmacol, 1991, 207, 361-364.
49. LeschKP, AulakhCS, WolozinBL, MurphyDL: Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression. Pharmacol Toxicol, 1992, 71, 49-60.
50. LeschKP, ManjiHK: Signal-transducing G proteins and antidepressant drugs: evidence for modulation of alpha subunit gene expression in rat brain. Biol Psychiatry, 1992, 32, 549-579.
51. Li H, Prince DA: Synaptic activity in chronically injured, epileptogenic sensory motor neocortex. J Neurophysiol, 2002, 88, 2-12. (Pubitemid 34755326)
52. López-RodríguezML, BenhamúB, MorcilloMJ, PorrasE, LavanderaJL, PardoL: Serotonin 5-HT7 receptor antagonists. Curr Med Chem Cent Nerv Syst Agents, 2004, 4, 203-214.
53. Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M: A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron, 1993, 11, 449-458. (Pubitemid 23287072)
54. Mackowiak M, O'Neill MJ, Hicks CA, Bleakman D, Skolnick P: An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study. Neuropharmacology, 2002, 43, 1-10. (Pubitemid 35245669)
55. Manji HK, Drevets WC, Charney DS: The cellular neurobiology of depression. Nat Med, 2001, 7, 541-547. (Pubitemid 32448319)
56. MatthysA, HaegemanG, Van CraenenbroeckK, VanhoenackerP: Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol Neurobiol, 2011, 43, 228-253.
57. Maura G, Marcoli M, Tortarolo M, Andrioli, M. Raiteri M: Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at 5-HT1D receptors. Br J Pharmacol, 1998, 123, 45-50. (Pubitemid 28036971)
58. McEvenBS, SapolskyRM: Stress and cognitive function, Curr Opin Neurobiol, 1995, 5, 205-216.
59. i2α) mRNA expression after electroconvulsive shock or lithium carbonate treatment. Eur J Pharmacol, 1996, 306, 249-255.
60. 7 receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat. Behav Brain Res, 2006, 167, 245-250.
61. Mnie-FilaliO, Lambas-SeńasL, ScarnaH, HaddjeriN: Therapeutic potential of 5-HT7 receptors in mood disorders. Curr Drug Targets, 2009, 10, 1109-1117.
62. Mnie-Filali O, Lambás-Seńas L, Zimmer L, Haddjeri N: 5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect, 2007, 20, 613-618. (Pubitemid 351437589)
63. 7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology, 1999, 21, 352-367.
64. MurrayF, SmithDV, HutsonPH: Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol, 2008, 583, 115-127.
65. NestlerEJ, HymanSE: Animal models of neuropsychiatric disorders. Nature Neurosc, 2010, 13, 1161-1169.
66. Nowak G, Li Y, Paul IA: Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment. Eur J Pharmacol, 1996, 295, 75-85. (Pubitemid 26027124)
67. Nowak G, Trullas R, Layer RT, Skolnick P, Paul IA: Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther, 1993, 265, 1380-1386. (Pubitemid 23321045)
68. O'Hearn E, Molliver ME: Organization of raphe-cortical projections in rat: a quantitive retrograde study. Brain Res Bull, 1984, 13, 709-726. (Pubitemid 15090392)
69. Okuhara DY, Beck SG, Muma NA: Corticosterone alters G protein a-subunit levels in the rat hippocampus. Brain Res, 1997, 745, 144-151. (Pubitemid 27055755)
70. Palucha A, Pilc A: The involvement of glutamate in the pathophysiology of depression. Drug News Perspect, 2005, 18, 262-268. (Pubitemid 41094930)
71. Parker KJ, Schatzberg AF, Lyons DM: Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav, 2003, 43, 60-66. (Pubitemid 36293275)
72. Paul IA, Skolnick P: Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci, 2003, 1003, 250-272. (Pubitemid 38083061)
73. Pavlides C, Nivon LG, McEwen BS: Effects of chronic stress on hippocampal long-term potentiation. Hippocampus, 2002, 12, 245-257. (Pubitemid 34436707)
74. Perkins MN, Stone TW: An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res, 1982, 247, 184-187. (Pubitemid 12028646)
75. Petrie RXA, Reid IC, Stewart CA: The N-methyl-D-aspartate receptor, synaptic plasticity and depressive disorder. Pharmacol Therapeut, 2000, 87, 11-25. (Pubitemid 30618985)
76. Pittenger C, Duman RS: Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology, 2008, 33, 88-109. (Pubitemid 350191319)
77. Raone A, Cassanelli A, Scheggi S, Rauggi R, Danielli B, De Montis MG: Hypothalamus-Pituitary-Adrenal modifications consequent to chronic stress exposure in an experimental model of depression in rats. Neuroscience, 2007, 146, 1734-1742. (Pubitemid 46783225)
78. RenW, PalazzoE, MaioneS, NeugebauerV: Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala. Neuropharmacology, 2011, 61, 1334-1344.
79. 7 receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. Br J Pharmacol, 2001, 132, 1574-1580.
80. 7 receptor-mediated effects on 5-HT efflux in the quinea-pig dorsal raphe nucleus. Neuropharmacology, 2004, 46, 935-941.
81. Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC: Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA, 1993, 90, 8547-8551. (Pubitemid 23277706)
82. Shen Y, Monsma FJ Jr, Metcalf MA, Jose PA, Hamblin MW, Sibley DR: Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem, 1993, 268, 18200-18204. (Pubitemid 23260343)
83. SkolnickP: Antidepressants for the new millennium. Eur J Pharmacol, 1999, 375, 31-40.
84. SleightAJ, CaroloC, PetitN, ZwingelsteinC, BoursonA: Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol Pharmacol, 1995, 47, 99-103.
85. 7 agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology, 2004, 46, 52-62.
86. SternerEY, KalynchukLE: Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: Relevance to depression. Prog Neuropsychopharmacol Biol Psychiatry, 2010, 34, 777-790.
87. SurgetA, SaxeM, LemanS, Ibarguen-VargasY, ChalonS, GriebelG, HenR, BelzungC: Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant. Reversal Biol Psychiatry, 2008, 64, 293-301.
88. 7 receptors. Curr Drug Targets CNS Neurol Disord, 2004, 3, 81-90.
89. 7 receptor antagonist, modulates REM sleep in rats. Br J Pharmacol, 2003, 139, 705-714.
90. 4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission. Pol J Pharmacol, 1996, 48, 565-573.
91. 7 receptor antagonist SB 269970 counteracts restraint stress-induced attenuation of long-term potentiation in rat frontal cortex. J Physiol Pharmacol, 2011, 62, 663-667.
92. TokarskiK, BobulaB, WabnoJ, HessG: Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience, 2008, 153, 789-795.
93. 7 receptors modulate GABAergic transmission in rat hippocampal CA1 area. J Physiol Pharmacol, 2011, 62, 535-540.
94. 7 receptors depresses glutamatergic transmission in the rat frontal cortex. J Physiol Pharmacol, 2012, 63, 173-177.
95. 7 receptors in rat hippocampus. J Physiol Pharmacol, 2009, 60, 83-88.
96. Tokarski K, Zahorodna A, Bobula B, Grzegorzewska M, Pitra P, Hess G: Repeated administration of citalopram and imipramine alters the responsiveness of rat hippocampal circuitry to the activation of 5-HT7 receptors. Eur J Pharmacol, 2005, 524, 60-66. (Pubitemid 41606814)
97. 7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Res, 2003, 993, 230-234.
98. 7 receptors in rat hippocampus. Pharmacol Rep, 2012, 64, 256-265.
99. Trullas R, Skolnick P: Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol, 1990, 185, 1-10. (Pubitemid 20254891)
100. WatersP, McCormickCM: Caveats of chronic exogenous corticosterone treatments in adolescent rats and effects on anxiety-like and depressive behavior and hypothalamic-pituitary-adrenal (HPA) axis function. Biol Mood Anxiety Disord, 2011, 1, 4-16.
101. 7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep, 2008, 60, 464-474.
102. 7 receptor antagonist in the forced swimming test in mice. Eur J Pharmacol, 2007, 555, 43-47.
103. 7 receptors: current knowledge and future prospects. Trends Pharmacol Sci, 2000, 21, 70-77.
104. YingSW, RusakB: 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons. Brain Res, 1997, 755, 246-254.
105. 7 receptor. Brain Res Bull, 2001, 54, 395-398.
106. YuJZ, DaveRH, AllenJA, SarmaT, RasenickMM: Cytosolic Gas acts as an intracellular messenger to increase microtubule dynamics and promote neurite outgrowth. J Biol Chem, 2009, 284, 10462-10472.
107. YuenEY, LiuW, KaratsoreosIN, RenY, FengJ, McEwenBS, YanZ: Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol Psychiatry, 2011, 16, 156-170.
108. 4 receptor activation in the CA1 area of rat hippocampus. Eur Neuropsychopharmacol, 2006, 16, 383-390.
109. ZhaoY, MaR, ShenJ, SuH, XingD, DuL: A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol, 2008, 58, 113-120.